Cargando…

Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man

AIMS: Small conductance Ca(2+)-activated K(+) channels (SK channels, K(Ca)2) are a new target for treatment of atrial fibrillation (AF). AP30663 is a small molecule inhibitor of K(Ca)2 channels that is currently in clinical development for treatment of AF. The aim of this study is to present the ele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bentzen, Bo Hjorth, Bomholtz, Sofia Hammami, Simó-Vicens, Rafel, Folkersen, Lasse, Abildgaard, Lea, Speerschneider, Tobias, Muthukumarasamy, Kalai Mangai, Edvardsson, Nils, Sørensen, Ulrik S., Grunnet, Morten, Diness, Jonas Goldin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232560/ https://www.ncbi.nlm.nih.gov/pubmed/32477117 http://dx.doi.org/10.3389/fphar.2020.00610

Ejemplares similares

The K(Ca)2 Channel Inhibitor AP14145, But Not Dofetilide or Ondansetron, Provides Functional Atrial Selectivity in Guinea Pig Hearts
por: Kirchhoff, Jeppe Egedal, et al.
Publicado: (2019)

The K(Ca)2 Channel Inhibitor AP30663 Selectively Increases Atrial Refractoriness, Converts Vernakalant-Resistant Atrial Fibrillation and Prevents Its Reinduction in Conscious Pigs
por: Diness, Jonas Goldin, et al.
Publicado: (2020)

Inhibition of K(Ca)2 Channels Decreased the Risk of Ventricular Arrhythmia in the Guinea Pig Heart During Induced Hypokalemia
por: Diness, Jonas Goldin, et al.
Publicado: (2020)

First Clinical Study with AP30663 ‐ a K(Ca)2 Channel Inhibitor in Development for Conversion of Atrial Fibrillation
por: Gal, Pim, et al.
Publicado: (2020)

Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca(2+)-Activated K(+) Channels in Pigs
por: Diness, Jonas Goldin, et al.
Publicado: (2017)

2,6-Bis(2-Benzimidazolyl)Pyridine (BBP) Is a Potent and Selective Inhibitor of Small Conductance Calcium-Activated Potassium (SK) Channels
por: Simó-Vicens, Rafel, et al.
Publicado: (2018)

Inhibition of K(Ca)2 and K(v)11.1 Channels in Pigs With Left Ventricular Dysfunction
por: Citerni, Carlotta, et al.
Publicado: (2020)

Characterization of Atrial and Ventricular Structural Remodeling in a Porcine Model of Atrial Fibrillation Induced by Atrial Tachypacing
por: Citerni, Carlotta, et al.
Publicado: (2020)

Impact of arrhythmogenic calmodulin variants on small conductance Ca(2+)‐activated K(+) (SK3) channels
por: Saljic, Arnela, et al.
Publicado: (2019)

Role of Calcium-activated Potassium Channels in Atrial Fibrillation Pathophysiology and Therapy
por: Diness, Jonas G., et al.
Publicado: (2015)

Antiarrhythmic effect of the Ca(2+)-activated K(+) (SK) channel inhibitor ICA combined with either amiodarone or dofetilide in an isolated heart model of atrial fibrillation
por: Kirchhoff, Jeppe Egedal, et al.
Publicado: (2016)

Small conductance calcium activated K(+) channel inhibitor decreases stretch induced vulnerability to atrial fibrillation
por: Yan, Yannan, et al.
Publicado: (2021)

Central and Peripheral GABA(A) Receptor Regulation of the Heart Rate Depends on the Conscious State of the Animal
por: Bentzen, Bo Hjorth, et al.
Publicado: (2011)

Effective termination of atrial fibrillation by SK channel inhibition is associated with a sudden organization of fibrillatory conduction
por: Gatta, Giulia, et al.
Publicado: (2021)

Low Voltage Activation of KCa1.1 Current by Cav3-KCa1.1 Complexes
por: Rehak, Renata, et al.
Publicado: (2013)

Contribution of the KCa3.1 channel–calmodulin interactions to the regulation of the KCa3.1 gating process
por: Morales, Patricia, et al.
Publicado: (2013)

MoKCa database—mutations of kinases in cancer
por: Richardson, Christopher J., et al.
Publicado: (2009)

Effects of KCa channels on biological behavior of trophoblasts
por: Zhang, Xiaolei, et al.
Publicado: (2022)

Whole-Exome Sequencing Implicates Neuronal Calcium Channel with Familial Atrial Fibrillation
por: Vad, Oliver Bundgaard, et al.
Publicado: (2022)

Novel Phenolic Inhibitors of Small/Intermediate-Conductance Ca(2+)-Activated K(+) Channels, KCa3.1 and KCa2.3
por: Oliván-Viguera, Aida, et al.
Publicado: (2013)

Pharmacological inhibition of SK‐channels with AP14145 prevents atrial arrhythmogenic changes in a porcine model for obstructive respiratory events
por: Linz, Benedikt, et al.
Publicado: (2022)

PI3KCA Mutations in Uterine Cervix Carcinoma
por: Voutsadakis, Ioannis A.
Publicado: (2021)

Investigating CFTR and KCa3.1 Protein/Protein Interactions
por: Klein, Hélène, et al.
Publicado: (2016)

Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
por: Jin, Lee‐Way, et al.
Publicado: (2019)

GTP-dependent regulation of myometrial KCa channels incorporated into lipid bilayers
Publicado: (1990)

Characterization of the PCMBS-dependent modification of KCa3.1 channel gating
por: Bailey, Mark A., et al.
Publicado: (2010)

KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo
por: D'Alessandro, G, et al.
Publicado: (2013)

KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma
por: Brown, Brandon M., et al.
Publicado: (2018)

Radiation Increases Functional KCa3.1 Expression and Invasiveness in Glioblastoma
por: D’Alessandro, Giuseppina, et al.
Publicado: (2019)

Modulation of Retrograde Trafficking of KCa3.1 in a Polarized Epithelium
por: Lee, Bob Shih-Liang, et al.
Publicado: (2017)

KCa3.1 Impairment Is Not Just a Slow Afterthought in Epilepsy
por: Gross, Christina
Publicado: (2020)

KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis
por: Huang, Chunling, et al.
Publicado: (2014)

KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages
por: Grimaldi, A, et al.
Publicado: (2016)

KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment
por: D'Alessandro, Giuseppina, et al.
Publicado: (2016)

Pharmacological Targeting of KCa Channels to Improve Endothelial Function in the Spontaneously Hypertensive Rat
por: Khaddaj Mallat, Rayan, et al.
Publicado: (2019)

KCa3.1 as an Effective Target for Inhibition of Growth and Progression of Intrahepatic Cholangiocarcinoma
por: Song, Penghong, et al.
Publicado: (2017)

Endothelial KCa channels: Novel targets to reduce atherosclerosis-driven vascular dysfunction
por: Vera, O. Daniel, et al.
Publicado: (2023)

Acrofacial vitiligo secondary to PI3KCA inhibitor, alpelisib: case report
por: Hinich, Maayan Geller, et al.
Publicado: (2023)

Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's Disease
por: Maezawa, Izumi, et al.
Publicado: (2012)

MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma
por: Kikuchi, Ken, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9239d04kj58gatcpfgibrl860g